vs

Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and ZIPRECRUITER, INC. (ZIP). Click either name above to swap in a different company.

ZIPRECRUITER, INC. is the larger business by last-quarter revenue ($111.7M vs $77.6M, roughly 1.4× Bioceres Crop Solutions Corp.). ZIPRECRUITER, INC. runs the higher net margin — -0.7% vs -9.6%, a 8.9% gap on every dollar of revenue. On growth, ZIPRECRUITER, INC. posted the faster year-over-year revenue change (0.6% vs -16.8%). Over the past eight quarters, ZIPRECRUITER, INC.'s revenue compounded faster (-4.4% CAGR vs -8.4%).

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

BIOX vs ZIP — Head-to-Head

Bigger by revenue
ZIP
ZIP
1.4× larger
ZIP
$111.7M
$77.6M
BIOX
Growing faster (revenue YoY)
ZIP
ZIP
+17.4% gap
ZIP
0.6%
-16.8%
BIOX
Higher net margin
ZIP
ZIP
8.9% more per $
ZIP
-0.7%
-9.6%
BIOX
Faster 2-yr revenue CAGR
ZIP
ZIP
Annualised
ZIP
-4.4%
-8.4%
BIOX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BIOX
BIOX
ZIP
ZIP
Revenue
$77.6M
$111.7M
Net Profit
$-7.4M
$-835.0K
Gross Margin
46.8%
89.1%
Operating Margin
9.3%
3.6%
Net Margin
-9.6%
-0.7%
Revenue YoY
-16.8%
0.6%
Net Profit YoY
-20.2%
92.3%
EPS (diluted)
$-0.12
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOX
BIOX
ZIP
ZIP
Q4 25
$111.7M
Q3 25
$77.6M
$115.0M
Q2 25
$112.2M
Q1 25
$60.6M
$110.1M
Q4 24
$98.8M
$111.0M
Q3 24
$93.3M
$117.1M
Q2 24
$123.7M
Q1 24
$84.0M
$122.2M
Net Profit
BIOX
BIOX
ZIP
ZIP
Q4 25
$-835.0K
Q3 25
$-7.4M
$-9.8M
Q2 25
$-9.5M
Q1 25
$-1.6M
$-12.8M
Q4 24
$605.2K
$-10.8M
Q3 24
$-6.2M
$-2.6M
Q2 24
$7.0M
Q1 24
$9.8M
$-6.5M
Gross Margin
BIOX
BIOX
ZIP
ZIP
Q4 25
89.1%
Q3 25
46.8%
89.1%
Q2 25
89.3%
Q1 25
39.4%
89.4%
Q4 24
42.0%
89.6%
Q3 24
40.2%
89.4%
Q2 24
89.5%
Q1 24
50.8%
89.1%
Operating Margin
BIOX
BIOX
ZIP
ZIP
Q4 25
3.6%
Q3 25
9.3%
-4.4%
Q2 25
-5.9%
Q1 25
1.5%
-10.6%
Q4 24
14.5%
-3.6%
Q3 24
2.5%
-2.8%
Q2 24
7.6%
Q1 24
15.7%
-0.7%
Net Margin
BIOX
BIOX
ZIP
ZIP
Q4 25
-0.7%
Q3 25
-9.6%
-8.5%
Q2 25
-8.5%
Q1 25
-2.6%
-11.7%
Q4 24
0.6%
-9.7%
Q3 24
-6.6%
-2.2%
Q2 24
5.7%
Q1 24
11.6%
-5.3%
EPS (diluted)
BIOX
BIOX
ZIP
ZIP
Q4 25
$-0.03
Q3 25
$-0.12
$-0.11
Q2 25
$-0.10
Q1 25
$-0.02
$-0.13
Q4 24
$0.00
$-0.10
Q3 24
$-0.10
$-0.03
Q2 24
$0.07
Q1 24
$0.14
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOX
BIOX
ZIP
ZIP
Cash + ST InvestmentsLiquidity on hand
$15.5M
$188.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$288.3M
$-77.2M
Total Assets
$734.9M
$569.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOX
BIOX
ZIP
ZIP
Q4 25
$188.0M
Q3 25
$15.5M
$211.8M
Q2 25
$203.5M
Q1 25
$38.5M
$221.1M
Q4 24
$29.2M
$218.4M
Q3 24
$32.3M
$225.6M
Q2 24
$271.7M
Q1 24
$16.4M
$282.5M
Stockholders' Equity
BIOX
BIOX
ZIP
ZIP
Q4 25
$-77.2M
Q3 25
$288.3M
$-76.1M
Q2 25
$-65.9M
Q1 25
$345.0M
$-11.3M
Q4 24
$346.3M
$13.4M
Q3 24
$346.0M
$13.6M
Q2 24
$24.4M
Q1 24
$348.5M
$12.7M
Total Assets
BIOX
BIOX
ZIP
ZIP
Q4 25
$569.7M
Q3 25
$734.9M
$573.6M
Q2 25
$592.4M
Q1 25
$798.2M
$629.4M
Q4 24
$835.2M
$664.1M
Q3 24
$827.3M
$652.0M
Q2 24
$665.3M
Q1 24
$836.1M
$662.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOX
BIOX
ZIP
ZIP
Operating Cash FlowLast quarter
$14.4M
$7.7M
Free Cash FlowOCF − Capex
$7.6M
FCF MarginFCF / Revenue
6.8%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$9.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOX
BIOX
ZIP
ZIP
Q4 25
$7.7M
Q3 25
$14.4M
$2.6M
Q2 25
$10.5M
Q1 25
$23.3M
$-9.9M
Q4 24
$-5.4M
$12.5M
Q3 24
$5.2M
$9.3M
Q2 24
$21.9M
Q1 24
$-17.4M
$2.0M
Free Cash Flow
BIOX
BIOX
ZIP
ZIP
Q4 25
$7.6M
Q3 25
$2.2M
Q2 25
$10.2M
Q1 25
$-10.2M
Q4 24
$12.0M
Q3 24
$9.2M
Q2 24
$21.7M
Q1 24
$1.9M
FCF Margin
BIOX
BIOX
ZIP
ZIP
Q4 25
6.8%
Q3 25
1.9%
Q2 25
9.1%
Q1 25
-9.3%
Q4 24
10.8%
Q3 24
7.8%
Q2 24
17.6%
Q1 24
1.6%
Capex Intensity
BIOX
BIOX
ZIP
ZIP
Q4 25
0.1%
Q3 25
0.3%
Q2 25
0.3%
Q1 25
0.3%
Q4 24
0.4%
Q3 24
0.2%
Q2 24
0.1%
Q1 24
0.1%
Cash Conversion
BIOX
BIOX
ZIP
ZIP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-8.85×
Q3 24
Q2 24
3.12×
Q1 24
-1.78×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BIOX
BIOX

Segment breakdown not available.

ZIP
ZIP

License$84.3M75%
Services$27.4M25%

Related Comparisons